Latest Period
Q1 2026
Security Snapshot
AIM ImmunoTech Inc. - Common stock, par value $0.001 per share (AIM) Institutional Ownership
CUSIP: 00901B303
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
17
Shares (Excl. Options)
175,756
Price
$0.58
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Symbol
- AIM on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 175,756
- Total 13F value
- $102,812
- Portfolio coverage rank
- 0%
- Share change
- +69,760
- Value change
- +$2,734
- Number of holders
- 17
- SEC-reported price per share
- $0.30
- Insider filing price
- $0.30
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AIM - AIM ImmunoTech Inc. - Common stock, par value $0.001 per share is tracked under CUSIP 00901B303.
- 17 institutions reported positions in Q1 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 17 to 0 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $102,812 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 17 institutions filings for Q1 2026.
Security key
00901B303
Latest holder period
Q1 2026
13F holders
17
13D/G owners
0
CIK / CUSIP context first
Open Q1 2026 holders
AIM full holder history
AIM ImmunoTech Inc. SEC filings
AIM ImmunoTech Inc. company facts
AIM ImmunoTech Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00901B303:
As of 31 Mar 2026, 17 institutional investors reported holding 175,756 shares of AIM ImmunoTech Inc. - Common stock, par value $0.001 per share (AIM).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5